HER2 testing in the UK: recommendations for breast and gastric in-situ hybridisation methods

Hdl Handle:
http://hdl.handle.net/10147/229951
Title:
HER2 testing in the UK: recommendations for breast and gastric in-situ hybridisation methods
Authors:
Bartlett, J. M. S.; Starczynski, J.; Atkey, N.; Kay, E.; O'Grady, A.; Gandy, M.; Ibrahim, M.; Jasani, B.; Ellis, I. O.; Pinder, S. E.; Walker, R. A.
Citation:
HER2 testing in the UK: recommendations for breast and gastric in-situ hybridisation methods 2011, 64 (8):649 Journal of Clinical Pathology
Journal:
Journal of Clinical Pathology
Issue Date:
2011
URI:
http://hdl.handle.net/10147/229951
DOI:
10.1136/jcp.2011.089847
Additional Links:
http://jcp.bmj.com/cgi/doi/10.1136/jcp.2011.089847
Abstract:
These guidelines supplement existing guidelines on HER2 testing by immunohistochemistry and in-situ hybridisation(ISH) methods in the UK. They provide a specific focus on aspects of guidance relevant to HER2 ISH testing methods, both fluorescent and chromogenic. They are formulated to give advice on methodology, interpretation and quality control for ISH-based testing of HER2 status in common tumour types, including both breast and gastric tumours. The aim is to ensure that all ISH-based testing is accurate, reliable and timely.
Item Type:
Article
Language:
en
ISSN:
0021-9746

Full metadata record

DC FieldValue Language
dc.contributor.authorBartlett, J. M. S.en_GB
dc.contributor.authorStarczynski, J.en_GB
dc.contributor.authorAtkey, N.en_GB
dc.contributor.authorKay, E.en_GB
dc.contributor.authorO'Grady, A.en_GB
dc.contributor.authorGandy, M.en_GB
dc.contributor.authorIbrahim, M.en_GB
dc.contributor.authorJasani, B.en_GB
dc.contributor.authorEllis, I. O.en_GB
dc.contributor.authorPinder, S. E.en_GB
dc.contributor.authorWalker, R. A.en_GB
dc.date.accessioned2012-06-20T14:11:17Z-
dc.date.available2012-06-20T14:11:17Z-
dc.date.issued2011-
dc.identifier.citationHER2 testing in the UK: recommendations for breast and gastric in-situ hybridisation methods 2011, 64 (8):649 Journal of Clinical Pathologyen_GB
dc.identifier.issn0021-9746-
dc.identifier.doi10.1136/jcp.2011.089847-
dc.identifier.urihttp://hdl.handle.net/10147/229951-
dc.description.abstractThese guidelines supplement existing guidelines on HER2 testing by immunohistochemistry and in-situ hybridisation(ISH) methods in the UK. They provide a specific focus on aspects of guidance relevant to HER2 ISH testing methods, both fluorescent and chromogenic. They are formulated to give advice on methodology, interpretation and quality control for ISH-based testing of HER2 status in common tumour types, including both breast and gastric tumours. The aim is to ensure that all ISH-based testing is accurate, reliable and timely.en_GB
dc.language.isoenen
dc.relation.urlhttp://jcp.bmj.com/cgi/doi/10.1136/jcp.2011.089847en_GB
dc.rightsArchived with thanks to Journal of Clinical Pathologyen_GB
dc.titleHER2 testing in the UK: recommendations for breast and gastric in-situ hybridisation methodsen_GB
dc.typeArticleen
dc.identifier.journalJournal of Clinical Pathologyen_GB
dc.description.provinceLeinsteren
All Items in Lenus, The Irish Health Repository are protected by copyright, with all rights reserved, unless otherwise indicated.